Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation.

Rip J, Nierman MC, Ross CJ, Jukema JW, Hayden MR, Kastelein JJ, Stroes ES, Kuivenhoven JA.

Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1236-45. Epub 2006 Mar 30. Review.

2.

Low HDL-C: a secondary target of dyslipidemia therapy.

Rosenson RS.

Am J Med. 2005 Oct;118(10):1067-77. Review.

PMID:
16194634
3.
4.

The effect of genetic variation on the lipid response to dietary change: recent findings.

Masson LF, McNeill G.

Curr Opin Lipidol. 2005 Feb;16(1):61-7. Review.

PMID:
15650565
5.

The influence of lipoprotein lipase gene variation on postprandial lipoprotein metabolism.

López-Miranda J, Cruz G, Gómez P, Marín C, Paz E, Pérez-Martínez P, Fuentes FJ, Ordovas JM, Pérez-Jiménez F.

J Clin Endocrinol Metab. 2004 Sep;89(9):4721-8.

PMID:
15356086
6.

Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease: the Veterans Affairs HDL Intervention Trial.

Brousseau ME, Goldkamp AL, Collins D, Demissie S, Connolly AC, Cupples LA, Ordovas JM, Bloomfield HE, Robins SJ, Schaefer EJ.

J Lipid Res. 2004 Oct;45(10):1885-91. Epub 2004 Aug 1.

7.

Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study.

Guthrie JR, Taffe JR, Lehert P, Burger HG, Dennerstein L.

Menopause. 2004 May-Jun;11(3):315-22.

PMID:
15167311
8.
9.

Effect of menopause on serum HDL-cholesterol level.

Sultan N, Nawaz M, Sultan A, Fayaz M, Baseer A.

J Ayub Med Coll Abbottabad. 2003 Jul-Sep;15(3):24-6.

PMID:
14727334
10.

Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease.

Boekholdt SM, Thompson JF.

J Lipid Res. 2003 Jun;44(6):1080-93. Epub 2003 Mar 16. Review.

11.

Hepatic lipase: structure/function relationship, synthesis, and regulation.

Perret B, Mabile L, Martinez L, Tercé F, Barbaras R, Collet X.

J Lipid Res. 2002 Aug;43(8):1163-9. Review.

12.

Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: effects of menopause.

Middelberg RP, Spector TD, Swaminathan R, Snieder H.

Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1142-7.

13.

Relation of the -514C/T polymorphism in the hepatic lipase gene to serum HDL and LDL cholesterol levels in postmenopausal women under hormone replacement therapy.

Yamakawa-Kobayashi K, Somekawa Y, Fujimura M, Tomura S, Arinami T, Hamaguchi H.

Atherosclerosis. 2002 May;162(1):17-21.

PMID:
11947893
14.

Plasma cholesterol esterification and transfer, the menopause, and hormone replacement therapy in women.

Lewis-Barned NJ, Sutherland WH, Walker RJ, Walker HL, De Jong SA, Edwards EA, Markham VH.

J Clin Endocrinol Metab. 1999 Oct;84(10):3534-8.

PMID:
10522991
15.

Apolipoprotein E and atherosclerosis: insight from animal and human studies.

Davignon J, Cohn JS, Mabile L, Bernier L.

Clin Chim Acta. 1999 Aug;286(1-2):115-43. Review.

PMID:
10511288
16.

Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis.

Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG.

Circulation. 1999 Jun 8;99(22):2901-7.

17.

Association between plasma HDL-cholesterol concentration and Taq1B CETP gene polymorphism in non-insulin-dependent diabetes mellitus.

Bernard S, Moulin P, Lagrost L, Picard S, Elchebly M, Ponsin G, Chapuis F, Berthezène F.

J Lipid Res. 1998 Jan;39(1):59-65.

18.
20.

Plasma cholesteryl ester transfer protein.

Tall AR.

J Lipid Res. 1993 Aug;34(8):1255-74. Review. No abstract available.

Supplemental Content

Support Center